project . 2016 - 2018 . Closed

CLLassify

Innovative risk assessment for individualizing treatment in chronic lymphocytic leukemia
Open Access mandate for Publications European Commission
  • Funder: European CommissionProject code: 702714 Call for proposal: H2020-MSCA-IF-2015
  • Funded under: H2020 | MSCA-IF-EF-ST Overall Budget: 164,653 EURFunder Contribution: 164,653 EUR
  • Status: Closed
  • Start Date
    01 Apr 2016
    End Date
    31 Mar 2018
  • Detailed project information (CORDIS)
  • Open Access mandate
    Research Data: No
Description
Chronic lymphocytic leukemia faces high-challenging and timely problems related to the classification and efficient prognosis of patients at the time of diagnosis and the attempt to personalize the treatment. CLLassify addresses these issues in a pioneering fashion within a multidisciplinary collaboration, proposing an improved classification of the patients, based on innovative statistical techniques as well as the novel aspect of personalized prediction of the need for treatment at a specific time point for the individual patient. The statistical background of the applicant, together with the expertise of his supervisor in CLL, guarantee the successful impleme...
Description
Chronic lymphocytic leukemia faces high-challenging and timely problems related to the classification and efficient prognosis of patients at the time of diagnosis and the attempt to personalize the treatment. CLLassify addresses these issues in a pioneering fashion within a multidisciplinary collaboration, proposing an improved classification of the patients, based on innovative statistical techniques as well as the novel aspect of personalized prediction of the need for treatment at a specific time point for the individual patient. The statistical background of the applicant, together with the expertise of his supervisor in CLL, guarantee the successful impleme...
Any information missing or wrong?Report an Issue